U S Physical Therapy Inc  (USPH)
Other Ticker:  
Price: $85.1400 $-0.54 -0.630%
Day's High: $87.55 Week Perf: -2.49 %
Day's Low: $ 85.02 30 Day Perf: 1.6 %
Volume (M): 67 52 Wk High: $ 124.11
Volume (M$): $ 5,696 52 Wk Avg: $99.12
Open: $85.85 52 Wk Low: $78.08

 Market Capitalization (Millions $) 1,276
 Shares Outstanding (Millions) 15
 Employees 6,700
 Revenues (TTM) (Millions $) 360
 Net Income (TTM) (Millions $) 42
 Cash Flow (TTM) (Millions $) 110
 Capital Exp. (TTM) (Millions $) 8

U S Physical Therapy Inc
U.S. Physical Therapy Inc. (USPH) is a publicly traded company headquartered in Houston, Texas, that provides outpatient physical therapy services through a network of clinics across 39 states in the United States. The company was founded in 1990 and has since grown to become a leading provider of physical therapy services, with over 600 clinics and 6,000 employees.

USPH focuses primarily on the treatment of orthopedic and sports-related injuries, as well as offering services for other physical impairments and disabilities. The company uses evidence-based practices and advanced technology to provide personalized treatment plans for patients, with the aim of improving their quality of life and helping them achieve their goals. USPH clinics offer a range of services, including manual therapy, exercise, massage, aquatic therapy, and other specialized treatments as required.

USPH's business model is built on a combination of self-operated clinics and partnerships with independent physical therapists. As of 2021, approximately two-thirds of the company's clinics are managed through partnerships with local therapists who maintain ownership of their clinics while benefitting from USPH's resources and expertise.

In addition to its core physical therapy services, USPH also operates a range of other healthcare services. These include management of workers' compensation claims, clinical research, and consulting services.

Since going public in 1992, USPH has seen significant growth, both in terms of its financial performance and its geographic reach. As of 2021, the company had a market capitalization of over $1 billion and was ranked as one of the fastest-growing healthcare companies in the United States. Looking ahead, USPH continues to focus on expanding its network of clinics and partnerships, developing new technologies, and providing high-quality care to its patients.

   Company Phone Number: 297-7000   Stock Exchange / Ticker: NYSE USPH
   USPH is expected to report next financial results on February 27, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Legacy Ventures International Inc

Legacy Ventures International Inc's Exceptional Financial Results in the Medical Equipment and Supplies Industry Indicate Strong Progress

As the July to September 30, 2023 reporting cycle resumes, various corporations, including Legacy Ventures International Inc in the Medical Equipment and Supplies sector, have announced their financial results. In a surprising turn of events, Legacy Ventures International Inc managed to conduct business more economically compared to the previous fiscal quarter, indicating positive signs of progress. This article will delve into the implications of these financial results and explore how they may impact the company going forward.
Improved Operating Deficit:
Legacy Ventures International Inc reported an operating deficit of $-0.006744 million for the July to September 30, 2023 three-month period, which is an improvement from the operating deficit of $-0.009667 million in the same period of the previous year. This significant reduction in operating deficit indicates that the company has been successful in implementing cost-saving measures and enhancing operational efficiency.

Vivos Inc

The company announced sturdy revenue rise, in the third quarter of 2023

For the fiscal third quarter of 2023 Vivos Inc reached break-even of $0.00 per share compare to $0.00 a year ago and from $0.00 per share from the preceding reporting season. The Revenue advanced by 7.692 % to $0.01 million from $0.01 million in the same reporting season a year ago and sequentially revenue advanced by 7.692 % from $0.01 million. Medical Equipment and Supplies company's has plainly outperformed its sector peers on the revenue facet, as the Medical Equipment and Supplies sector report 5.93% in the same period top-line advance thus far.

Nephros Inc

The company declared epic recent numbers, over the financial period closing Sep 30 2023

For the July to September 30 2023 financial time-frame Nephros Inc decreased a loss per share of $-0.02 per share compare to $-0.31 a year ago and EPS improved from $-0.04 per share from the previous quarter. The revenue jumped by 32.586 % to $3.19 million from $2.41 million in the corresponding quarter a year ago and sequentially revenue surged by 3.735 % from $3.08 million. Medical Equipment and Supplies company's revenue rose faster compared to the the top-line at virtually all of the Medical Equipment and Supplies industry peers, in the third quarter of 2023 the majority entities in Medical Equipment and Supplies sectors made an average revenue improvement of 5.93% relative to the corresponding period a year ago.

Vystar Corporation

Vystar Corporation's Financial Report Reveals Shocking Decline: Stakeholders Left Disappointed

Vystar Corporation, a renowned company in the industry, recently released its financial report for the second quarter of 2023. Unfortunately, the figures have left stakeholders and investors disappointed. The report reveals a substantial decline in revenue, an increase in shortfall per share, and a net deficit compared to the previous year's figures. This article aims to shed light on the financial performance of Vystar Corporation during this period and the potential factors contributing to these disappointing results.
A Dismal Second Quarter
Vystar Corporation's financial performance for the second quarter of 2023 was disastrous. Revenue plunged by an alarming 98.87% to a mere $0.04 million compared to $0.41 million in the same period in the previous year. This sharp decline can be attributed to the company's struggle to maintain demand for its products. Vystar Corporation also experienced a significant increase in shortfall per share, rising from $0.00 to $-0.04.

Non Invasive Monitoring Systems Inc

Non Invasive Monitoring Systems Inc Surprises Investors with Significant Fiscal Improvement, Despite Operating Loss

Investors Analyze Non Invasive Monitoring Systems Inc's Earnings and Future Performance
Experts in the Medical Equipment and Supplies industry are closely examining the fourth quarter earnings report of Non Invasive Monitoring Systems Inc (NIMU). The company reported an operating loss of $-0.033 million for the period between May and July 2023. Notably, the company has not cited any revenue for the same reporting period.
Comparatively, the operating loss for the fourth quarter of 2022 stood at $-0.035 million, serving as a crucial indicator for the overall performance of the company. As NIMU and other ascending corporations in the industry aim to develop their business strategies, the need for cost-effectiveness becomes increasingly important to progress to the next stage.


U S Physical Therapy Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com